Immunotherapy Biomarkers and Patient Selection [360p]
Dr. Julie Brahmer, Johns Hopkins University, discusses the use of biomarker testing and mutational burden to select patients for specific immunotherapies in lung cancer, renal cell carcinoma and melan...
Author: cancergrace
Added: 03/15/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | John Hopkins University | Kidney Cancer | Lung Cancer | Renal Cell Carcinoma